Last week the government announced a new National Genomic Healthcare Strategy that focuses on providing predictive, personalised health services to people with rare diseases. It builds on Health and Social Care Secretary Matt Hancock’s ambition to sequence 5 million genomes in the UK by 2023 to 2024, and will be developed in collaboration with the National Genomics Board and the broader genomics community.

At the same time, the House of Commons Science and Technology Committee has launched an inquiry into commercial genomic testing. The inquiry will look at a range of topics, including the ability of genomic testing to return accurate health results, the potential risks and benefits to the NHS, sufficient data protection and the availability of support (including counselling) for those receiving results.


Back to e-newsletter